4.6 Review

Common Misconceptions About Lyme Disease

Journal

AMERICAN JOURNAL OF MEDICINE
Volume 126, Issue 3, Pages -

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.amjmed.2012.10.008

Keywords

Bannwarth syndrome; Borrelia burgdorferi; Diagnosis; Erythema migrans; Lyme disease; Serology; Treatment

Funding

  1. Centers for Disease Control and Prevention (CDC)
  2. CDC
  3. National Institutes of Health
  4. Immunetics, Inc.
  5. BioRad
  6. DiaSorin, Inc.
  7. BioMerieux

Ask authors/readers for more resources

Lyme disease, infection with Borrelia burgdorferi, is a focally endemic tick-transmitted zoonosis. During the 3 decades since the responsible spirochete was identified, a series of misconceptions and misunderstandings have become widely prevalent, leading to frequent misdiagnosis and inappropriate treatment. Persistent misconceptions concern the reliability of available diagnostic tools, the signs and symptoms of nervous system involvement, the appropriate choice and duration of antimicrobial therapy, the curability of the infection, and the cause of symptoms that may persist in some patients after treatment. Concern about disparate perspectives led the Institute of Medicine to review the subject. In this article we review the principal misconceptions, discussing their origins and the best currently available scientific evidence related to each one. (C) 2013 Elsevier Inc. All rights reserved. The American Journal of Medicine (2013) 126, 264.e1-264.e7

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available